Article
Very high uptake of risk-reducing salpingo-oophorectomy in BRCA1/2 mutation carriers: A single-center experience.
Gynecologic oncology - 1 Oct 2016
Harmsen M G, Arts-de Jong M, Horstik K, Manders P, Massuger L F A G, Hermens R P M G, Hoogerbrugge N, Woldringh G H, de Hullu J A
Abstract excerpt
OBJECTIVE: Risk-reducing salpingo-oophorectomy (RRSO) is the only effective surgical strategy to reduce the increased risk of epithelial ovarian cancer in BRCA1/2 mutation carriers. Given the long-term health consequences of premature surgical menopause, we need insight in uptake and timing of RRSO to guide us in improving healthcare. METHODS: A single-center retrospective cohort study of BRCA1/2 mutation...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
